Abstract
Over 50% of successfully treated choroidal neovascular membranes (CNVMs) associated with age-related macular degeneration (AMD) develop recurrences within 2 years of treatment. Most of these recurrences will have occurred 6 to 12 months following initial treatment. Unfortunately, almost all recurrences occur contiguous with the foveal side of the treatment scar, invariably resulting in further visual loss. Possible risk factors felt to be related to an increased rate of recurrence are cigarette smoking, CNVMs located closer to the center of the fovea on initial presentation and CNVMs with very light pigmentation. Additional risk factors need to be identified that may predict which eyes are likely to develop recurrences. Closer follow-up of this high risk group may allow ophthalmologists to identify recurrences earlier, before they have extended through the foveal avascular zone and destroyed central vision.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Macular Photocoagulation Study Group: Argon laser photocoagulation for senile macular degeneration: Results of a randomized clinical trial. Arch Ophthalmol 100:912–918, 1982.
Macular Photocoagulation Study Group: Argon laser photocoagulation for neovascular maculopathy: three year results from randomized clinical trials. Arch Ophthalmol 104:694–701, 1986.
Coscas G, Soubrane G: Photcoagulation des neovaisseaux sous-retiniens dans la degenerescence maculaire senile par laser a argon. Resultats de l’etude randomisee de 60 cas. Bull Mem Soc Fr Ophthalmol 94:149–154, 1982.
Moorfields Macular Study Group: Treatment of senile disciform macular degeneration: a single-blind randomised trial by argon laser photocoagulation. Br J Ophthalmol 66:745–753, 1982.
Macular Photocoagulation Study Group: Recurrent choroidal neovascularization after argon laser photocoagulation for neovascular maculopathy. Arch Ophthalmol 104:503–512, 1986.
Sorenson JA, Yannuzzi LA, Shakin JL: Recurrent subretinal neovascularization. Ophthalmology 92:1059–1072, 1985.
Sarks SH: New vessel formation beneath the retinal pigment epithelium in senile eyes. Aust J Ophthalmol 8:117–130, 1980.
Fleiss JL: Statistical Methods for Rates and Proportions, 2nd ed. New York: John Wiley & Sons, 1981.
Rice TA, Murphy RP, Fine SL et al: Stability of size of argon laser photocoagulation scars in ocular histoplasmosis, in Fine SL, Owens SL (eds): Management of Retinal Vascular and Macular Disorders. Baltimore: Williams and Wilkins Co, 1983, pp 187–190.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1987 Martinus Nijhoff/Dr W. Junk Publishers, Dordrecht
About this chapter
Cite this chapter
Bressler, N.M., Bressler, S.B., Murphy, R.P., Fine, S.L. (1987). Recurrent Choroidal Neovascularization Following Successful Photocoagulation in Age-Related Macular Degeneration. In: BenEzra, D., Ryan, S.J., Glaser, B.M., Murphy, R.P. (eds) Ocular Circulation and Neovascularization. Documenta Ophthalmologica Proceedings Series, vol 50. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-3337-8_41
Download citation
DOI: https://doi.org/10.1007/978-94-009-3337-8_41
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-7999-0
Online ISBN: 978-94-009-3337-8
eBook Packages: Springer Book Archive